Benzinga··Globe NewswireChemed Expands Capital Return Program With $300M Buyback Authorization
Chemed authorizes $300M share buyback and declares $0.60 quarterly dividend, demonstrating confidence in cash generation and commitment to shareholder returns.
CHEcapital allocationdividend